Overview: |
Title: Equity Risk Management for Concentrated Single Stock Positions and Tailored Portfolio Solutions |
Date: Friday, February 23, 2024 |
Time: 1:00 PM Eastern Standard Time |
Duration: 1 hour |
Register Now: |
Already Registered? |
Summary: |
||
Now On Demand |
||
Speakers: |
||
|
||
Lou Mandia spearheads RIA Strategy at Morgan Stanley within the Institutional Equity Division, strategizing with clients on bespoke portfolio solutions to achieve targeted outcomes. Prior to joining Morgan Stanley, Lou spent three years at UBS spearheading RIA and Broker Dealer distribution, and six years at Goldman Sachs & Co, focused on structured investments and cross-asset distribution within the Global Markets Division. |
||
|
||
Jenn is Head of Equity Risk Management distribution at Morgan Stanley and is based in New York. For the last 16 years, Jenn’s work has concentrated on providing derivative solutions for Institutional clients across asset managers, corporate & public pensions, endowments & foundations, fund of funds, bank platforms, insurance companies, OCIOs and family offices. As capital markets activity upticks at Morgan Stanley, Jenn has been tasked to focus on concentrated equity positions in the RIA and Family Office community. |
The information provided herein was prepared by sales, trading, or other non-research personnel of one of the following: Morgan Stanley & Co. LLC, Morgan Stanley & Co. International PLC, Morgan Stanley MUFG Securities Co., Ltd, Morgan Stanley Capital Group Inc. and/or Morgan Stanley Asia Limited (together with their affiliates, hereinafter “Morgan Stanley”) but is not a product of the Morgan Stanley Research Department or prepared by the Morgan Stanley Research Department. This communication is a marketing communication and is not a research report, though it may refer to a Morgan Stanley Research report or the views of a Morgan Stanley research analyst. We are not commenting on the fundamentals of any companies mentioned. For additional information and important disclosures, see http://www.morganstanley.com/disclaimers.
An investment in OTC strategies may not be suitable for all investors. These investments involve substantial risks. The appropriateness of a particular investment or strategy will depend on an investor’s individual circumstances and objectives. This material does not provide individually tailored investment advice, nor does it offer tax, regulatory, accounting or legal advice.
The information provided herein has been prepared solely for informational purposes and is not an offer or a solicitation of an offer to enter into any over-the-counter derivative transaction. No representation is given with respect to the information’s accuracy or completeness, and it may change without notice. Morgan Stanley, on its own behalf and on behalf of its affiliates, disclaims any and all liability relating to these materials, including, without limitation, any express or implied representations or warranties for statements or errors contained in, or omissions from, these materials. Morgan Stanley is not advising you to take any particular action based on the information, opinions or views contained herein, and acceptance of such document will be deemed by you acceptance of these conclusions. You should consult with your own municipal, financial, accounting and legal advisors regarding the information, opinions or views contained in this communication.
© 2024 Morgan Stanley